Institutional investors purchased a net $585.0 thousand shares of ALXA during the quarter ended December 2012 and now own 37.45% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Other industry and highlights that the smart money sees this stock as an important holding.
| Individual stakeholders | 9.42% |
| Other institutional | 26.09% |
| Mutual fund holders | 11.36% |